Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Cyclophosphamide 641 Bevacizumab 552 Paclitaxel 534 Carboplatin 533 Cisplatin 480 pembrolizumab 456 Gemcitabine 422 Docetaxel 415 Rituximab 386 Radiotherapy 373 Dexamethasone 351 Doxorubicin 330 Nivolumab 308 Fluorouracil 286 Capecitabine 260 Etoposide 245 Prednisone 244 Oxaliplatin 242 Erlotinib Hydrochloride 242 Cytarabine 233 Lenalidomide 232 Trastuzumab 226 Pemetrexed 220 Vincristine 212 fludarabine phosphate 208 Leucovorin 208 Cetuximab 208 Filgrastim 204 Bortezomib 193 Methotrexate 183

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has results × Appointments and Schedules × Clear all

NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed

252 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡